NCT07635316
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
Gastro-enteropancreatic neuroendocrine tumor
Explore clinical trials studying Gastro-enteropancreatic neuroendocrine tumor. Study availability and eligibility vary by location and protocol.
46 public trials
19 recruiting studies
Gastro-enteropancreatic neuroendocrine tumor trial results
NCT07165132
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
- Locations
-
- Research Facility Iowa City, Iowa, United States
- Research Facility Lexington, Kentucky, United States
- Research Facility St Louis, Missouri, United States
- Research Facility St Louis, Missouri, United States
Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
NCT05636618
- Conditions
- Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Biogenix Molecular Miami, Florida, United States
- The University of Chicago Chicago, Illinois, United States
- University of Iowa Iowa City, Iowa, United States
NCT06441331
- Conditions
- CNS Tumors, Central Nervous System Neoplasms, GIST, +29 more
- Locations
-
- The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
- Gustave Roussy Cancer Campus Villejuif, France
- Hospital Universitario Vall d'Hebron - Oncología Médica Barcelona, Spain
NCT06784752
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- Hartford Hospital Hartford, Connecticut, United States
NCT05477576
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
- Locations
-
- Research Facility Phoenix, Arizona, United States
- Research Facility Duarte, California, United States
- Research Facility Irvine, California, United States
- Research Facility Los Angeles, California, United States
NCT04090034
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
- Locations
-
- Clinical Research Institute at Methodist Health System Dallas, Texas, United States
- Methodist Dallas Medical Center Dallas, Texas, United States
NCT07150546
- Conditions
- Digestive System Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor, Unresectable Digestive System Neuroendocrine Neoplasm, +2 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital Atlanta, Georgia, United States
NCT06356467
- Conditions
- GEP-NET, Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, +5 more
- Locations
-
- IRCCS OSpedale San Raffaele Milan, Italy
NCT07302100
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
- Locations
-
- Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France Strasbourg, France